Journal Editorial Report: The week's worst and best from Kim Strassel, Jason Riley, Allysia Finley and Kyle Peterson. Images: Zuma Press/AFP/Getty Images Composite: Mark Kelly
The pharmaceutical company Merck claims in a lawsuit filed this week that the “Drug Price Negotiation Program for Medicare,” part of last summer’s Inflation Reduction Act, is an unconstitutional taking of company’s property and a violation of the company’s freedom of speech. If successful, this lawsuit will prevent the unconstitutional practice of forcing drug companies to sell drugs to the U.S. government at a government-determined price.